spiperone has been researched along with aripiprazole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Deng, X; Fu, W; Guo, L; Xu, L; Yu, K; Zhao, W; Zhen, X | 1 |
| Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
| Hide, I; Hirose, T; Inoue, A; Kikuchi, T; Koga, N; Nakata, Y; Seto, M; Sugita, S | 1 |
| Burris, KD; Kikuchi, T; Molinoff, PB; Molski, TF; Ryan, E; Tottori, K; Xu, C; Yocca, FD | 1 |
| Akaike, A; Izumi, Y; Kume, T; Matsuo, T; Sawada, H; Takada-Takatori, Y; Wakita, S | 1 |
| Beninger, RJ; Lister, JG; Rocca, JF | 1 |
1 review(s) available for spiperone and aripiprazole
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
6 other study(ies) available for spiperone and aripiprazole
| Article | Year |
|---|---|
Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Ligands; Molecular Structure; Quinazolines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2015 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Cell Membrane; Gene Expression Regulation; Haloperidol; Male; Piperazines; Pituitary Gland; Prolactin; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Ribonucleases; RNA, Messenger; Spiperone | 1998 |
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Antipsychotic Agents; Aripiprazole; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; GTP-Binding Proteins; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Signal Transduction; Spiperone | 2002 |
Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Ascorbic Acid; Biological Transport; Dopamine; Extracellular Space; Gene Expression Regulation, Enzymologic; Haloperidol; Homovanillic Acid; Mesencephalon; Neurons; Pargyline; PC12 Cells; Pimozide; Piperazines; Quinolones; Rats; Spiperone; Transport Vesicles; Tyrosine 3-Monooxygenase | 2010 |
Spiroperidol, but not eticlopride or aripiprazole, produces gradual increases in descent latencies in the bar test in rats.
Topics: Animals; Aripiprazole; Behavior, Animal; Conditioning, Psychological; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Motivation; Rats; Rats, Wistar; Receptors, Dopamine; Salicylamides; Spiperone | 2017 |